Literature DB >> 19823070

Radiotherapy after surgical resection for head and neck mucosal melanoma.

Abraham J Wu1, Jennifer Gomez, Joanne E Zhung, Kelvin Chan, Daniel R Gomez, Suzanne L Wolden, Michael J Zelefsky, Jedd D Wolchok, Richard D Carvajal, Paul B Chapman, Richard J Wong, Ashok R Shaha, Dennis H Kraus, Jatin P Shah, Nancy Y Lee.   

Abstract

OBJECTIVES: To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck.
METHODS: Between 1992 and 2007, 27 patients with mucosal melanoma of the head and neck underwent surgical resection followed by postoperative radiotherapy. Median age was 68 years (range: 45-89 years). Sites included were sinonasal in 24 patients, oral cavity in 2, and oropharynx in 1. All but 2 patients had stage I disease. Twenty-two patients received hypofractionated radiation. Radiation techniques were intensity-modulated radiation therapy in 13, 3-dimensional conformal in 4, and conventional in 10.
RESULTS: The median follow-up for living patients was 45 months (range: 24-122 months). The 3- and 5-year estimates of local progression-free, loco-regional progression-free, distant metastasis-free, and overall survival were: 47% and 35%; 34% and 22%; 30% and 24%; and 40% and 33%, respectively. Median time to local failure and distant metastasis was 32 and 14 months, respectively. Acute toxicities included 19% with grade 2 or higher mucositis. No late complications related to the optic structures were seen.
CONCLUSIONS: Modern radiotherapeutic techniques including intensity-modulated radiation therapy appear feasible and well-tolerated in the postoperative treatment of head and neck mucosal melanoma. Unusual or serious late complications have not been observed despite extensive use of hypofractionated regimens. However, rates of local and distant failure remain high.

Entities:  

Mesh:

Year:  2010        PMID: 19823070     DOI: 10.1097/COC.0b013e3181a879f5

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  16 in total

Review 1.  Mucosal melanoma: pathogenesis, clinical behavior, and management.

Authors:  Michael A Postow; Omid Hamid; Richard D Carvajal
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

Review 2.  Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.

Authors:  Michael Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

Review 3.  Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Authors:  Jun Guo; Shukui Qin; Jun Liang; Tongyu Lin; Lu Si; Xiaohong Chen; Zhihong Chi; Chuanliang Cui; Nan Du; Yun Fan; Kangsheng Gu; Fang Li; Junling Li; Yongheng Li; Houjie Liang; Jiwei Liu; Man Lu; Aiping Lu; Kejun Nan; Xiaohui Niu; Hongming Pan; Guoxin Ren; Xiubao Ren; Yongqian Shu; Xin Song; Min Tao; Baocheng Wang; Wenbin Wei; Di Wu; Lingying Wu; Aiwen Wu; Xiaolin Xu; Junyi Zhang; Xiaoshi Zhang; Yiping Zhang; Huiyan Zhu
Journal:  Ann Transl Med       Date:  2015-12

4.  Predictors of survival in mucosal melanoma of the head and neck.

Authors:  Daniel Jethanamest; Peter M Vila; Andrew G Sikora; Luc G T Morris
Journal:  Ann Surg Oncol       Date:  2011-04-08       Impact factor: 5.344

5.  Sino-nasal mucosal malignant melanoma.

Authors:  Muneeb Uddin Karim; Khursheed Khan; Nasir Ali; Mubasher Ikram
Journal:  BMJ Case Rep       Date:  2015-04-29

Review 6.  National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.

Authors:  Arnold Pompos; Robert L Foote; Albert C Koong; Quynh Thu Le; Radhe Mohan; Harald Paganetti; Hak Choy
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

Review 7.  Update on primary head and neck mucosal melanoma.

Authors:  Fernando López; Juan P Rodrigo; Antonio Cardesa; Asterios Triantafyllou; Kenneth O Devaney; William M Mendenhall; Missak Haigentz; Primož Strojan; Phillip K Pellitteri; Carol R Bradford; Ashok R Shaha; Jennifer L Hunt; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

8.  Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.

Authors:  Robert M Samstein; Richard D Carvajal; Michael A Postow; Margaret K Callahan; Alexander N Shoushtari; Snehal G Patel; Nancy Y Lee; Christopher A Barker
Journal:  Head Neck       Date:  2016-04-04       Impact factor: 3.147

9.  Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.

Authors:  Alexandra D Jensen; Anna V Nikoghosyan; Swantje Ecker; Malte Ellerbrock; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2011-04-05       Impact factor: 3.481

10.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.